Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials
oleh: McNeil Ngongondo, Justin Ritz, Michael D. Hughes, Mitch Matoga, Mina C. Hosseinipour
| Format: | Article |
|---|---|
| Diterbitkan: | Public Library of Science (PLoS) 2024-01-01 |
Deskripsi
No description available for this item.